Regardless of cracking 90 it is holding well.So it should soon to be debt free or close to it, low production costs. Potential to add to an established resource.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago